Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M74,967Revenue $M10,299Net Margin (%)33.9Altman Z-Score13.1
Enterprise Value $M73,197EPS $14.8Operating Margin %45.1Piotroski F-Score9
P/E(ttm)21.1Beneish M-Score-2.2Pre-tax Margin (%)44.8Higher ROA y-yY
Price/Book5.910-y EBITDA Growth Rate %26.5Quick Ratio1.9Cash flow > EarningsY
Price/Sales7.35-y EBITDA Growth Rate %25.5Current Ratio2.2Lower Leverage y-yY
Price/Free Cash Flow22.9y-y EBITDA Growth Rate %44.7ROA % (ttm)23.9Higher Current Ratio y-yY
Dividend Yield %--PEG0.8ROE % (ttm)31.7Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M235ROIC % (ttm)36.6Gross Margin Increase y-yY

Gurus Latest Trades with BIIB

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
BIIBVanguard Health Care Fund 2015-06-30 Add1.17%$373.93 - $430.96
($401.66)
$ 318.78-21%Add 425.02%1,780,330
BIIBKen Fisher 2015-06-30 Reduce$373.93 - $430.96
($401.66)
$ 318.78-21%Reduce 0.16%80,932
BIIBVanguard Health Care Fund 2015-03-31 Buy 0.31%$334.65 - $475.98
($394.14)
$ 318.78-19%New holding339,100
BIIBJoel Greenblatt 2015-03-31 Sold Out -0.014%$334.65 - $475.98
($394.14)
$ 318.78-19%Sold Out0
BIIBKen Fisher 2015-03-31 Add$334.65 - $475.98
($394.14)
$ 318.78-19%Add 2.28%81,058
BIIBMario Gabelli 2015-03-31 Reduce$334.65 - $475.98
($394.14)
$ 318.78-19%Reduce 0.06%4,932
BIIBKen Heebner 2014-12-31 Sold Out -0.75%$299.1 - $360.67
($323.29)
$ 318.78-1%Sold Out0
BIIBVanguard Health Care Fund 2014-12-31 Sold Out -0.2%$299.1 - $360.67
($323.29)
$ 318.78-1%Sold Out0
BIIBJoel Greenblatt 2014-12-31 Reduce-0.08%$299.1 - $360.67
($323.24)
$ 318.78-1%Reduce 84.03%5,012
BIIBKen Heebner 2014-09-30 Buy 0.75%$299.29 - $346.3
($329.79)
$ 318.78-3%New holding80,000
BIIBVanguard Health Care Fund 2014-09-30 Reduce-0.27%$299.29 - $346.3
($329.79)
$ 318.78-3%Reduce 58.26%233,600
BIIBJoel Greenblatt 2014-09-30 Buy 0.1%$299.29 - $346.3
($329.79)
$ 318.78-3%New holding31,391
BIIBKen Heebner 2014-06-30 Sold Out -0.95%$274 - $320.13
($300.74)
$ 318.786%Sold Out0
BIIBKen Fisher 2014-06-30 Add0.05%$274 - $320.13
($300.74)
$ 318.786%Add 386.61%88,885
BIIBVanguard Health Care Fund 2014-06-30 Reduce-0.03%$274 - $320.13
($301.05)
$ 318.786%Reduce 6.62%559,700
BIIBJoel Greenblatt 2014-06-30 Sold Out -0.02%$274 - $320.13
($300.74)
$ 318.786%Sold Out0
BIIBGeorge Soros 2014-06-30 Sold Out -0.02%$274 - $320.13
($300.74)
$ 318.786%Sold Out0
BIIBRon Baron 2014-06-30 Add$274 - $320.13
($300.74)
$ 318.786%Add 41.76%8,632
BIIBMario Gabelli 2014-06-30 Add$274 - $320.13
($301.05)
$ 318.786%Add 16.46%4,175
BIIBKen Heebner 2014-03-31 Buy 0.95%$273.518 - $351.94
($316.4)
$ 318.781%New holding116,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

BIIB is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


BIIB: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
PAPADOPOULOS STELIOSDirector 2015-07-27Buy10,000$304.884.56view
Posner Brian SDirector 2015-06-22Sell470$415-23.19view
WILLIAMS DOUGLAS EEVP Research & Development 2015-06-19Sell3,841$410-22.25view
Posner Brian SDirector 2015-06-15Sell400$386.64-17.55view
SCANGOS GEORGE ACEO 2015-06-01Sell1,362$398.87-20.08view
SCANGOS GEORGE ACEO 2015-05-01Sell1,362$377.52-15.56view
SCANGOS GEORGE ACEO 2015-04-01Sell1,362$423.2-24.67view
Sandrock AlfredGrp SVP, Chief Medical Officer 2015-03-27Sell430$430.12-25.89view
Cox JohnEVP Pharmaceutical Oper & Tech 2015-03-25Sell12,010$449.06-29.01view
Rowinsky Eric KDirector 2015-03-20Sell11,667$475-32.89view

Quarterly/Annual Reports about BIIB:

News about BIIB:

Articles On GuruFocus.com
shortlist Jul 19 2015 
shortlist Jul 19 2015 
shortlist Jul 19 2015 
shortlist Jul 19 2015 
Investment Strategies for the Bullish Biotech Sector Jun 01 2015 
Apple, SunEdison and Biogen: Hellman, Jordan Management's Top 3 Stocks Outperform the Rise in the S& May 28 2015 
PRIMECAP Sells Portions of Its Top Two Stakes May 27 2015 
8 Top Healthcare Stocks to Watch May 13 2015 
Biogen Making A Breakthrough In Treating Alzheimer’s May 02 2015 
Vanguard Healthcare Fund Adds Four New Positions May 01 2015 

More From Other Websites
Biogen’s Experimental Alzheimer Therapy: Limited 2Q15 Success Jul 31 2015
These are the Biggest Risk to Biotech Jul 31 2015
Biogen: Positive 2Q15 Results for Multiple Sclerosis Pipeline Drugs Jul 31 2015
Key for Investors: Why Did Biotech Stocks Fall? Jul 31 2015
​How many multiple sclerosis patients are in the U.S.? No one knows. Jul 30 2015
Biogen Can Get Growth Spurt It Needs With Vertex Deal: Real M&A Jul 30 2015
BIOGEN INC. Financials Jul 30 2015
Biogen: Reports of Its Demise 'Have (Probably!) Been Greatly Exaggerated' Jul 30 2015
Biogen’s Hemophilia Portfolio: Growing Market Share in 2Q15 Jul 30 2015
The Zacks Analyst Blog Highlights: Biogen, AbbVie, Regeneron, Amgen and XOMA - Press Releases Jul 30 2015
Biogen’s Multiple Sclerosis Drugs Show 2Q15 Growth Jul 30 2015
​Sanofi calls out Genzyme, multiple sclerosis drug, as main drivers of growth again Jul 30 2015
​Here are all the Boston-area biotechs about to buy or get bought Jul 29 2015
Biotech Stock Roundup: Biogen Down on Tecfidera Issues, Regeneron's Praluent Gets FDA Nod - Analyst... Jul 29 2015
Four Reasons Gilead Can Head Higher Jul 29 2015
Biogen’s Weak 2Q15 Tecfidera Performance Dampens Sentiment Jul 29 2015
5 Stocks Insiders Love Right Now Jul 29 2015
A vote of confidence for Biogen as chairman buys $3M shares Jul 29 2015
Insiders Were Buying Up Shares Of Biogen Inc (BIIB) And These Other Companies Yesterday Jul 28 2015

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK